Boardroom Alpha
10-Q primary document
SKIL · Quarterly Report (Form 10-Q) · Filed June 9, 2026

Skillsoft Corp10-Q exhibit

ex_973530.htm
ex_973530.htm

Exhibit 10.9

 

June 1, 2026

 

 

Scott Semel

Via Email

 

Dear Scott,

 

Per the terms of your offer letter with Skillsoft Corp. (the “Company”) dated November 17, 2025 (the “Offer Letter”), your employment may be extended beyond the Initial Term (as defined in the Offer Letter) by mutual agreement. This letter serves to acknowledge the extension of your employment term with the Company for an additional three months, from May 16, 2026 through August 16, 2026, inclusive (the “Extended Term”).

 

During the Extended Term, you shall be expected to work (i) 40 hours per week for the period from May 16, 2026 through June 5, 2026, inclusive (the “Full Time Portion”) and (ii) at least five hours per week for the period from June 6, 2026 through August 16, 2026, inclusive, unless sooner terminated by you (the “Part Time Portion”). For your service during the Full Time Portion, your base salary shall remain at the rate as set forth in the Offer Letter. For your service during the Part Time Portion, your base salary rate shall be changed to $1,682.69 for each week worked (pro-rated for partial weeks). For the avoidance of doubt, you shall not be eligible to participate in the Company’s annual cash bonus program for the fiscal year 2027 performance period.

 

The Talent and Compensation Committee of the Company’s Board of Directors has approved the grant of the Additional RSUs (as defined in the Offer Letter), which you shall receive in accordance with the terms and conditions in the Offer Letter.

 

During the period from June 6, 2026 through August 16, 2026, if you remain employed by the Company with your required level of service at five hours per week, such level of service shall constitute continued employment with the Company during such period for purposes of satisfying the vesting condition applicable to the Additional RSUs.

 

Except as set forth in this letter, the Offer Letter is unaffected and shall continue in full force and effect in accordance with its terms. If there is conflict between this letter and the Offer Letter, the terms of this letter shall prevail.

 

If the foregoing is acceptable to you, please sign this letter in the space provided and return it to me. At the time you sign and return it, this letter will take effect as a binding agreement between you and the Company on the basis set forth above.

 

We look forward to the continued benefit of your expertise and leadership.

 

 

 

Sincerely,

 

 

/s/ Ciara Harrington      
Ciara Harrington      
Chief People Officer      

 

 

ACCEPTED:

 

 

/s/ Scott Semel   June 2, 2026  
Scott Semel   Date  

 

 
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer